OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current Guidelines for Management of Medullary Thyroid Carcinoma
Mijin Kim, Bo Hyun Kim
Endocrinology and Metabolism (2021) Vol. 36, Iss. 3, pp. 514-524
Open Access | Times Cited: 64
Mijin Kim, Bo Hyun Kim
Endocrinology and Metabolism (2021) Vol. 36, Iss. 3, pp. 514-524
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
Ali Doostmohammadi, Hossein Jooya, Kimia Ghorbanian, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 36
Ali Doostmohammadi, Hossein Jooya, Kimia Ghorbanian, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 36
Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3643-3643
Open Access | Times Cited: 34
Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3643-3643
Open Access | Times Cited: 34
Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect
Linnea Højer Wang, Markus Wehland, Petra M. Wise, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2312-2312
Open Access | Times Cited: 22
Linnea Højer Wang, Markus Wehland, Petra M. Wise, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2312-2312
Open Access | Times Cited: 22
Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine
Giorgio Treglia, Vittoria Rufini, Arnoldo Piccardo, et al.
Seminars in Nuclear Medicine (2023) Vol. 53, Iss. 4, pp. 481-489
Open Access | Times Cited: 19
Giorgio Treglia, Vittoria Rufini, Arnoldo Piccardo, et al.
Seminars in Nuclear Medicine (2023) Vol. 53, Iss. 4, pp. 481-489
Open Access | Times Cited: 19
Current and future of immunotherapy for thyroid cancer based on bibliometrics and clinical trials
Ke Wang, Ying Zhang, Xing Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Ke Wang, Ying Zhang, Xing Yang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Is desmoplastic stromal reaction useful to modulate lymph node dissection in sporadic medullary thyroid carcinoma?
Priscilla Francesca Procopio, Francesco Pennestrì, Nikolaos Voloudakis, et al.
Surgery (2024), pp. 108881-108881
Closed Access | Times Cited: 4
Priscilla Francesca Procopio, Francesco Pennestrì, Nikolaos Voloudakis, et al.
Surgery (2024), pp. 108881-108881
Closed Access | Times Cited: 4
Thyrotoxicosis With Medullary Thyroid Carcinoma: A Rare Endocrine Diagnostic Challenge
G Balamurugan, Nivash Selvaraj, Sahana Kannan
Cureus (2025)
Open Access
G Balamurugan, Nivash Selvaraj, Sahana Kannan
Cureus (2025)
Open Access
Diagnosis and treatment of a rare bilateral primary thyroid cancer: a case report
Hai Lin, Xinyu Zhang, Na Yan, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Hai Lin, Xinyu Zhang, Na Yan, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Synchronous thyroid medullary cancer and thyroid hemiagenesis: A case report
Chunyang Li, Chengbin Zhang, Chao Ma, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 4, pp. 1-5
Open Access
Chunyang Li, Chengbin Zhang, Chao Ma, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 4, pp. 1-5
Open Access
Simultaneous Medullary and Papillary Thyroid Carcinomas: Personal Experience Report and Literature Review
Nadia De Falco, Massimo Agresti, Massimo De Falco, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1382-1382
Open Access
Nadia De Falco, Massimo Agresti, Massimo De Falco, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1382-1382
Open Access
Celastrol promotes apoptotic cell death in thyroid cancer cells through a caspases-dependent pathway
Ruoyi Yang, Jie Yao, Hong Ma, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Ruoyi Yang, Jie Yao, Hong Ma, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Molecular oncology of iodine refractory thyroid cancer current therapies and perspective
François Cherifi, Ahmad Awada
Critical Reviews in Oncology/Hematology (2025), pp. 104679-104679
Closed Access
François Cherifi, Ahmad Awada
Critical Reviews in Oncology/Hematology (2025), pp. 104679-104679
Closed Access
Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
Yuxin Shen, Fengsheng Hong, Hualu Wu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yuxin Shen, Fengsheng Hong, Hualu Wu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Photodynamic Therapy for Thyroid Cancer
Julia Inglot, Joanna Katarzyna Strzelczyk, Dorota Bartusik‐Aebisher, et al.
BioMed (2025) Vol. 5, Iss. 1, pp. 8-8
Open Access
Julia Inglot, Joanna Katarzyna Strzelczyk, Dorota Bartusik‐Aebisher, et al.
BioMed (2025) Vol. 5, Iss. 1, pp. 8-8
Open Access
The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs
Sara Gil‐Bernabé, Lucía García‐DeLaFuente, Ginesa García‐Rostán
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3663-3663
Open Access
Sara Gil‐Bernabé, Lucía García‐DeLaFuente, Ginesa García‐Rostán
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3663-3663
Open Access
Simultaneous medullary thyroid carcinoma and primary non-small cell lung cancer: case report and literature review
Jianyong Zhang, Yu Zheng, An Xiaoxiao, et al.
Research Square (Research Square) (2025)
Closed Access
Jianyong Zhang, Yu Zheng, An Xiaoxiao, et al.
Research Square (Research Square) (2025)
Closed Access
Medullary thyroid carcinoma
Maria Rosa Pelizzo, Esmeralda Isabella Mazza, Caterina Mian, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 9, pp. 943-957
Open Access | Times Cited: 10
Maria Rosa Pelizzo, Esmeralda Isabella Mazza, Caterina Mian, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 9, pp. 943-957
Open Access | Times Cited: 10
Combining radiomics with thyroid imaging reporting and data system to predict lateral cervical lymph node metastases in medullary thyroid cancer
Zhiqiang Liu, Xiwei Zhang, Xiaohui Zhao, et al.
BMC Medical Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Zhiqiang Liu, Xiwei Zhang, Xiaohui Zhao, et al.
BMC Medical Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
False-Negative 68Ga-FAPI PET/CT in Pediatric Thyroid Medullary Carcinoma Seen With 68Ga-DOTATOC PET/CT and 18F-FDG PET/CT
Mohamad Haidar, Farah A. Abou Zeid, Zarouhie Meguerian, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 7, pp. 690-692
Closed Access | Times Cited: 3
Mohamad Haidar, Farah A. Abou Zeid, Zarouhie Meguerian, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 7, pp. 690-692
Closed Access | Times Cited: 3
Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers
Faraat Ali, Kumari Neha, Garima Chauhan
Archives of Pharmacal Research (2022) Vol. 45, Iss. 5, pp. 309-327
Closed Access | Times Cited: 12
Faraat Ali, Kumari Neha, Garima Chauhan
Archives of Pharmacal Research (2022) Vol. 45, Iss. 5, pp. 309-327
Closed Access | Times Cited: 12
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3991-3991
Open Access | Times Cited: 12
Giuseppe Fanciulli, Roberta Modica, Anna La Salvia, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3991-3991
Open Access | Times Cited: 12
Diffuse C-Cells Hyperplasia Is the Source of False Positive Calcitonin Measurement in FNA Washout Fluids of Thyroid Nodules: A Rational Clinical Approach to Avoiding Unnecessary Surgery
Chiara Mura, Rossella Rodia, Silvia Corrias, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 210-210
Open Access | Times Cited: 2
Chiara Mura, Rossella Rodia, Silvia Corrias, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 210-210
Open Access | Times Cited: 2
B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma
Pengtao Song, Yongcan Xu, Guochao Ye
Diagnostic Pathology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Pengtao Song, Yongcan Xu, Guochao Ye
Diagnostic Pathology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Elevated procalcitonin levels can occur in bacterial infections and also in medullary thyroid carcinoma
Fatih Öner Kaya, Tarek Alsafdi
European Journal of Case Reports in Internal Medicine (2024)
Open Access | Times Cited: 2
Fatih Öner Kaya, Tarek Alsafdi
European Journal of Case Reports in Internal Medicine (2024)
Open Access | Times Cited: 2
Diagnostics and treatment of differentiated thyroid carcinoma in children — Guidelines of the Polish National Scientific Societies, 2024 Update
Daria Handkiewicz-Junak, Marek Niedziela, Andrzej Lewiński, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 6, pp. 565-591
Open Access | Times Cited: 2
Daria Handkiewicz-Junak, Marek Niedziela, Andrzej Lewiński, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 6, pp. 565-591
Open Access | Times Cited: 2
